D Himanshu Reddy
Overview
Explore the profile of D Himanshu Reddy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
52
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Singh S, Verma A, Venkatesh V, Verma S, Reddy D, Agrawal A
Indian J Crit Care Med
. 2025 Jan;
28(11):1044-1049.
PMID: 39882045
Aims And Background: Carbapenem-resistant (CRAb), a major public health threat, causes severe infections in Intensive Care Unit (ICU) patients. It resists β-lactam antibiotics through mechanisms like New Delhi metallo-beta-lactamase (NDM)....
2.
Bharti J, Chandra T, Solanki A, Singh A, Reddy D, Agarwal M
J Family Med Prim Care
. 2024 Jul;
13(6):2503-2506.
PMID: 39027862
Thrombotic thrombocytopenic purpura (TTP) is a life-threatening disease present with the classic pentad of microangiopathic hemolytic anemia (MAHA), fever, neurologic changes, thrombocytopenia, and renal dysfunction. In a diagnostic dilemma, therapeutic...
3.
Reddy D, Atam V, Rai P, Khan F, Pandey S, Malhotra H, et al.
Clin Epidemiol Glob Health
. 2024 Apr;
15:101044.
PMID: 38620969
Introduction: Newer coexisting conditions should be identified in order to modify newer risk factors. Aim was to identify patients with non-classical or less common coexisting conditions in patients infected of...
4.
Reddy D, Kapoor R, Rai P, Atam V, Khan F, Pandey S, et al.
Lung India
. 2023 Apr;
40(2):123-127.
PMID: 37006095
Background And Aims: There is an increasing recognition of reinfection in coronavirus disease 2019 (COVID-19). We studied the reinfection of COVID-19 disease among doctors at a tertiary care centre in...
5.
Pandey S, Malhotra H, Garg R, Sharma K, Rizvi I, Kumar S, et al.
J Infect Public Health
. 2022 Oct;
15(11):1265-1269.
PMID: 36272391
Background: Rhino cerebral mucormycosis is an uncommon opportunistic infection of the nasal sinuses and brain, and a group of saprophytic fungi causes it. During the second wave of COVID-19, India...
6.
Mishra S, Dubey D, Agarwal K, Dubey D, Verma S, Shabbir N, et al.
Indian J Clin Biochem
. 2022 Aug;
38(2):172-181.
PMID: 36032561
Lymphocyte dysregulation in coronavirus disease-19 (COVID-19) is a major contributing factor linked to disease severity and mortality. Apoptosis results in the accumulation of cell-free DNA (cfDNA) in circulation. COVID-19 has...
7.
Chauhan H, Atam V, Sawlani K, Reddy D
J Assoc Physicians India
. 2022 Apr;
70(4):11-12.
PMID: 35443424
Material: This was a prospective observational study conducted on 81 patients of acute ischemic stroke after obtaining informed consent. A detailed history was taken and clinical examination was done. Serum...
8.
Baluni M, Ghildiyal S, Fatima T, Tiwari R, Upadhyay S, Dhole T, et al.
J Med Virol
. 2021 Oct;
94(2):531-539.
PMID: 34698413
Japanese encephalitis is one of the serious vector-borne viral encephalitis diseases found worldwide and poses a major threat to public health. Most Japanese encephalitis virus (JEV) infections are subclinical; only...
9.
Ghildiyal S, Fatima T, Singh D, Upadhyay S, Dhole T, Reddy D, et al.
Cytokine
. 2021 Oct;
149:155716.
PMID: 34634652
Background: Japanese encephalitis virus (JEV) is the major cause of viral encephalitis in many regions of Asia. Cytokines, including pro-inflammatory and anti-inflammatory are key regulators playing a detrimental role in...
10.
Mammen J, Kumar S, Thomas L, Kumar G, Zachariah A, Jeyaseelan L, et al.
BMJ Open
. 2021 Oct;
11(10):e050571.
PMID: 34607865
Objective: Large data on the clinical characteristics and outcome of COVID-19 in the Indian population are scarce. We analysed the factors associated with mortality in a cohort of moderately and...